Mesangial proliferative glomerulonephritis is a hard condition to treat. The regular treatments only focus on treating high blood pressure, proteinuria, high cholesterol levels and other symptoms. However, those treatments alone is not enough to stop the condition from progressing.
Bird flu vaccine. The Food and Drug Administration has approved one vaccine to prevent infection with one strain of H5N1 bird flu virus. This vaccine isn't available to the public, but the U.S. government is stockpiling it and will distribute it in the event of an outbreak.
Recombinant Flu Vaccines. There is a third production technology for flu vaccines that was approved for use in the U.S. market in 2013 and that involves using recombinant technology. This production method does not require an egg-grown vaccine virus and does not use chicken eggs at all in the production process.ecombinant flu vaccine is the only 100% egg-free vaccine on the U.S. market. There are other vaccines on the U.S. market that use similar recombinant manufacturing processes.